the pre-treatment tcr repertoire as a predicative biomarker in nsclc
Published 2 years ago • 40 plays • Length 3:08Download video MP4
Download video MP3
Similar videos
-
2:53
assessing the predicative value of the pre-treatment tcr repertoire
-
28:54
airrc7 - tcr repertoire as biomarker for autoimmune and inflammatory diseases (e. mariotti)
-
6:06
airrc6 - tcr repertoire as biomarker of immune diseases: autoimmunity and covid-19 (p. stys)
-
30:23
biophysicochemical motifs in tcr antigen binding regions as potential biomarkers of cancer
-
27:34
tcr signatures as biomarkers of autoimmune diseases
-
26:45
tcr targets validation through t cell activation
-
36:14
tumor immunology
-
8:46
today immunotherapy can cure even fourth stage cancer: dr dattatreyudu nori
-
4:29
advances in personalized medicine in nslc
-
6:58
cytoshrink study
-
33:34
airrc5 - detect cancer from the peripheral blood tcr repertoire (b. li)
-
6:18
mechanism of action of tmod™ t-cell therapy and pre-clinical evidence
-
16:58
assessing immune biomarkers of response to anthracyclines in breast cancer
-
1:20
(pro)renin receptor: an emerging biomarker and target for fighting cancer
-
42:00
surprisingly small effective size of the human tcr repertoire
-
2:53
immunotherapy: a revolution in cancer treatment
-
4:38
immunotherapia y cancer
-
13:31
cellprothera
-
4:20
utilizing neoantigen-specific tcrs for personalized immunotherapies
-
2:38
lung cancer: from immunotherapy to precision medicine
-
7:31
proscern® dc-t cell proliferation assay
-
8:12
airrc5 - clonomap tcr immune profiler (a. das)